The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome: a Multi-center, Prospective, Open Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04981145

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:26:07.895964+00:00

Published At

2024-10-16T00:00:00+00:00

Record Updated At

2024-10-16

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Primary Sj\u00f6gren\u0027s Syndrome"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2024-10-16"

protocolSection.identificationModule.nctId

"NCT04981145"

protocolSection.identificationModule.officialTitle

"The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sj\u00f6gren\u0027s Syndrome: a Multi-center, Prospective, Open Study"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE4"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Primary Sjögren's Syndrome (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.